MedTrace Logo

Study of the Impact of Digital Health Interventions on Symptom & Side-Effect Management in Metastatic Sarcoma Patients

NCT07642375 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 108

Last updated 2026-06-11

No results posted yet for this study

Summary

The objective of this prospective study is to capture the quality of life of patients with locally advanced or metastatic sarcoma, and investigate the effectiveness of support provided through a personalized web-based platform.

Conditions

  • Advanced Sarcoma
  • Metastatic Sarcoma

Interventions

BEHAVIORAL

Digital support

Personalized educational and supportive material, based on each patients' adverse events reported as PROs, delivered via the online platform.

Sponsors & Collaborators

  • CareAcross

    lead INDUSTRY

  • Hellenic Group of Sarcomas & Rare Cancers (HGSRC)

    collaborator UNKNOWN

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-08-22
Primary Completion
2026-08-31
Completion
2027-02-28

Countries

  • Greece

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07642375 on ClinicalTrials.gov